go back

California rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $436,516 · 10th–90th $436,516–$436,5160%50%100%$436,516Professionalmedian $501,187 · 10th–90th $129–$630,9570%20%40%10th90th$501,187$100.0$500.0$2.0K$10.0K$50.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Kaiser Permanente
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$128.82 / $398.11 / $831.76
Lucent Health
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$436,515.83 / $436,515.83 / $436,515.83
Lucent Health
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$630,957.34 / $630,957.34 / $630,957.34
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$501,187.23 / $501,187.23 / $549,540.87